surgebright
surgebright GmbH is an Austrian medtech company that manufactures the Shark Screw®, an allograft bone screw made from human donor bone for orthopedic and trauma surgery, serving hospitals and surgeons across 5 countries with a US distribution entity in Denver.
- Company typePrivate
- Founded2016
- HeadquartersLichtenberg, Austria
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What surgebright does
surgebright GmbH is an Austrian privately-held medtech company founded in 2016, headquartered in Lichtenberg bei Linz, Austria, that manufactures and distributes the Shark Screw®, an allograft bone screw made entirely from human cortical donor bone. The product is engineered with preserved Haversian canal architecture that enables natural bone cell colonization and gradual replacement of the implant by the patient's own bone tissue within 1-2 years, eliminating the need for a second surgery to remove metal hardware. The company has co-developed the screw portfolio with Graz University of Technology (TU Graz) to produce variants of differing strength for different surgical indications, and supports use across more than 40 indications in foot, ankle, hand, knee, and pediatric orthopedic and trauma surgery.
The company operates a tissue bank in Austria and a US distribution entity (surgebright Inc., Denver, Colorado), serving orthopedic surgeons, trauma surgeons, and hospitals in 5 countries through a sales-led model combining direct hospital sales with a network of distribution partners. Go-to-market emphasizes clinical evidence (8,000+ cases with 1-10 year follow-up; 87 publications and congress presentations), surgeon training (Surgebright Lab wet-lab courses, hospitations, webinars), and a network of 500+ certified surgeons. Beyond the flagship Shark Screw, the portfolio includes complementary allograft products (Spongiosa & Granulate, Demineralized Bone Matrix, Femoral Heads, Osteotomy Wedges & Diaphyses, Tendons & Skin). Pricing is quote-based and not publicly disclosed, and capital raised to date is modest (a $900,000 aws Preseed round in 2018), with ownership concentrated in the founding Pastl family. The company has accumulated 16,339+ documented Shark Screw cases globally but reports revenue and headcount only as ranges (11-50 employees), with no public financials disclosed.
surgebright firmographics
Firmographics- Name
- surgebright
- Legal name
- surgebright GmbH
- Website
- https://surgebright.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- surgebright GmbH is an Austrian medtech company that manufactures the Shark Screw®, an allograft bone screw made from human donor bone for orthopedic and trauma surgery, serving hospitals and surgeons across 5 countries with a US distribution entity in Denver.
- Ownership category
- akta.pro rank
surgebright industry classification
Industry- Product category
- Orthopedic Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)
- akta.pro secondary industry
- Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)
Keywords
Where surgebright is headquartered
LocationHeadquarters
- HQ city
- Lichtenberg
- HQ country
- Austria
- HQ region
- Europe
Offices2 records
Markets served
surgebright business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales (Allograft Products): Surgebright generates revenue through the sale of allograft bone products including Shark Screw bone screws and related bone graft materials (Spongiosa, Granulate, Demineralisierte Knochenmatrix, Hüftköpfe, Osteotomiekeile & Diaphysen, Tendons & Skin) to orthopedic surgeons and hospitals.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Medical device sales - quote-based pricing for hospitals and distributors |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels8 records
surgebright product offering
Product offeringCore offering
surgebright manufactures and distributes the Shark Screw®, an allograft bone screw made entirely from human cortical donor bone, used for osteosynthesis in orthopedic and trauma surgery. The screw's Haversian canal architecture allows natural bone cell colonization and gradual replacement by the patient's own bone within 1–2 years, eliminating the need for metal removal surgery. The company also offers a portfolio of complementary allograft bone graft materials (spongiosa, granulate, demineralized bone matrix, femoral heads, osteotomy wedges, tendons, and skin) to hospitals, surgeons, and distribution partners across Europe and the United States.
Product overview
surgebright GmbH is an Austrian medical device company (tissue bank) offering a portfolio of human allograft products for orthopedic and trauma surgery. The core product is the Shark Screw®, an allograft bone screw made from human cortical donor bone. The product portfolio includes bone screws, cancellous bone grafts, demineralized bone matrix, femoral heads, osteotomy wedges, and soft tissue allografts (tendons and skin). The Shark Screw® integrates into the natural bone remodeling process and does not require removal surgery, distinguishing it from conventional metal implants. The company serves surgeons across 5 countries with over 16,000+ documented cases and 500+ certified surgeons.
Differentiator
Problem solved
Functional benefit
Brands
- Shark Screw®: Allograft bone screw made entirely from human cortical donor bone that integrates with the body and eliminates the need for removal surgery. Used for fractures, non-unions, osteotomies, and arthrodeses.
Products and services
- Shark Screw® An allograft bone screw made entirely from human cortical donor bone. The screw integrates with the body's natural bone remodeling process through Haversian canals, allowing bone cells and blood vessels to colonize the implant. The screw is gradually replaced by the patient's own bone tissue within 1–2 years, eliminating the need for removal surgery. Indicated for orthopedic and trauma surgeons performing foot, hand, knee, and pediatric bone fixation across 40+ indications.
- Spongiosa & Granulate Bone graft material consisting of spongiosa (cancellous bone) and granules used for bone defect filling and augmentation procedures in orthopedic surgery.
- Demineralized Bone Matrix (Demineralisierte Knochenmatrix, DBM) Demineralized bone matrix used as bone graft material with osteoinductive properties for orthopedic and trauma surgery applications.
- Femoral Heads (Hüftköpfe) Femoral head allografts sourced from donor tissue for use in orthopedic reconstruction procedures.
- Osteotomy Wedges & Diaphyses (Osteotomiekeile & Diaphysen) Pre-shaped osteotomy wedges and diaphyseal bone segments for orthopedic corrective surgery applications.
- Tendons & Skin (Sehnen & Haut) Tendon and skin allografts for orthopedic and reconstructive surgical procedures.
Quantifiable outcome
- Clinical outcomes equal to or better than conventional metal implants across 8,000+ cases with 1-10 year follow-up
- +2 more outcomes
Companies that use surgebright
Customer profileNamed customers5 records
Segments2 records
Ideal customer profiles1 record
surgebright technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
surgebright partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- TU Graz (Graz University of Technology)coreJoint development partnership with Graz University of Technology for engineering Shark Screw bone screws of varying strengths. The collaboration ensures maximum stability and safety for different clinical applications and surgical requirements.
Scale indicators5 records
Recent moves6 records
Expansion highlights4 records
surgebright competitors and assessment
Company assessmentBroad incumbents
- Stryker: One of the world's largest orthopedic and medical device companies, offering a broad portfolio of trauma fixation, joint replacement, and surgical implants. While it does not offer an allograft bone screw equivalent, Stryker competes for the same hospital budgets and surgeon relationships that surgebright targets.
- Zimmer Biomet: Global leader in orthopedic reconstructive and trauma implants with deep hospital relationships across Europe and the US. Competes indirectly with surgebright in bone fixation and bone graft substitute markets through its broader portfolio.
- DePuy Synthes (Johnson & Johnson MedTech): The dominant player in orthopedic trauma fixation (plates, screws, nails), directly competing with Shark Screw for use in fracture fixation indications across all geographies where surgebright operates.
- Smith+Nephew: Major orthopedic and sports medicine company with established bone graft substitute offerings. Provides indirect competition through adjacent fixation and biologics products targeted at the same orthopedic surgeon customer base.
- Arthrex: Private orthopedic device leader focused on sports medicine, foot/ankle, and hand surgery—the same surgical specialties where surgebright's Shark Screw is most frequently used. Strong surgeon education programs parallel surgebright's wet-lab strategy.
- Integra LifeSciences: Diversified medical device company with a meaningful orthopedic and tissue technologies segment, including allograft and regenerative products. Competes in overlapping bone graft and fixation product categories.
Direct peers
- MTF Biologics: One of the largest US-based tissue banks supplying allograft bone grafts, soft tissue, and osteobiologic products. Directly comparable as a tissue-bank competitor supplying similar allograft bone products to orthopedic surgeons and hospitals.
- Bioventus: Specialized orthobiologics company offering bone graft substitutes and joint preservation products. Directly comparable as a focused competitor in the bone healing and graft substitute market that surgebright addresses with its DBM and Spongiosa portfolio.
Emerging players
- OSSDSIGN: Swedish medtech company developing patient-specific bone graft substitutes for orthopedic and neurosurgical applications. Comparable as a smaller, innovation-focused bone graft substitute company competing in adjacent indications.
- BoneSupport: Swedish orthopedic specialist developing synthetic bone graft substitutes (CERAMENT) for trauma and revision surgery. Comparable as a European-headquartered orthobiologics specialist competing in similar indications and hospital channels.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
surgebright social profiles
Digital presencesurgebright financial estimates
Financial estimateRevenue estimate
Valuation estimate
surgebright leadership team
Management profileNumber of profiles
Profiles3 records
surgebright subsidiaries and ownership
Company hierarchySubsidiaries1 record
surgebright funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
surgebright M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about surgebright
What does surgebright do?
surgebright manufactures and distributes the Shark Screw®, an allograft bone screw made entirely from human cortical donor bone, used for osteosynthesis in orthopedic and trauma surgery. The screw's Haversian canal architecture allows natural bone cell colonization and gradual replacement by the patient's own bone within 1–2 years, eliminating the need for metal removal surgery. The company also offers a portfolio of complementary allograft bone graft materials (spongiosa, granulate, demineralized bone matrix, femoral heads, osteotomy wedges, tendons, and skin) to hospitals, surgeons, and distribution partners across Europe and the United States.
Is surgebright a public or private company?
surgebright is a private company. It is classified as family owned and is currently operating.
When was surgebright founded?
surgebright was founded in 2016. It employs 11 to 50 people.
Where is surgebright based?
surgebright is headquartered in Lichtenberg, Austria, in the Europe region.
How does surgebright make money?
One revenue line is on record: medical Device Sales (Allograft Products).
Who are surgebright's main competitors?
Broad incumbents on record are Stryker, Zimmer Biomet, DePuy Synthes (Johnson & Johnson MedTech), Smith+Nephew, Arthrex and Integra LifeSciences. Direct peers are MTF Biologics and Bioventus. Emerging players are OSSDSIGN and BoneSupport.
Does surgebright have an API?
No public API is recorded for surgebright.
What industry is surgebright in?
surgebright's product category is Orthopedic Medical Devices. Its primary akta.pro industry code is HLAHAEAB, Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation), with a secondary code of HLAHAEAG, Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM). Its NAICS code is 339113 and its SIC code is 3842.